🇺🇸 DOXORUBICIN HYDROCHLORIDE in United States

18,193 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 3,530 reports (19.4%)
  2. Febrile Neutropenia — 3,182 reports (17.49%)
  3. Neutropenia — 2,003 reports (11.01%)
  4. Product Use In Unapproved Indication — 1,633 reports (8.98%)
  5. Disease Progression — 1,578 reports (8.67%)
  6. Pyrexia — 1,542 reports (8.48%)
  7. Nausea — 1,292 reports (7.1%)
  8. Anaemia — 1,257 reports (6.91%)
  9. Thrombocytopenia — 1,117 reports (6.14%)
  10. Vomiting — 1,059 reports (5.82%)

Source database →

DOXORUBICIN HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DOXORUBICIN HYDROCHLORIDE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for DOXORUBICIN HYDROCHLORIDE in United States?

Marketing authorisation holder not available in our data.